CA2347967A1 - Substance for reduction of cholesterol as well as lipids content - Google Patents

Substance for reduction of cholesterol as well as lipids content Download PDF

Info

Publication number
CA2347967A1
CA2347967A1 CA002347967A CA2347967A CA2347967A1 CA 2347967 A1 CA2347967 A1 CA 2347967A1 CA 002347967 A CA002347967 A CA 002347967A CA 2347967 A CA2347967 A CA 2347967A CA 2347967 A1 CA2347967 A1 CA 2347967A1
Authority
CA
Canada
Prior art keywords
substance
cholesterol
microcrystalline chitosan
reduction
lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002347967A
Other languages
English (en)
French (fr)
Inventor
Harri Hakli
Erkki Wuolijoki
Pauli Ylitalo
Harri Pomoell
Henryk Struszczyk
Elina Saynatjoki
Marketta Wulff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novasso Oy
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2347967A1 publication Critical patent/CA2347967A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA002347967A 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content Abandoned CA2347967A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI982291 1998-10-23
FI982291A FI982291A (fi) 1998-10-23 1998-10-23 Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi
PCT/FI1999/000885 WO2000024785A1 (en) 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content

Publications (1)

Publication Number Publication Date
CA2347967A1 true CA2347967A1 (en) 2000-05-04

Family

ID=8552763

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347967A Abandoned CA2347967A1 (en) 1998-10-23 1999-10-25 Substance for reduction of cholesterol as well as lipids content

Country Status (7)

Country Link
EP (1) EP1144458A1 (fi)
JP (1) JP2002528571A (fi)
CN (1) CN1331703A (fi)
AU (1) AU1048600A (fi)
CA (1) CA2347967A1 (fi)
FI (1) FI982291A (fi)
WO (1) WO2000024785A1 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029524A1 (en) * 2004-09-15 2006-03-23 Magistral Biotech Inc. Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443471A1 (en) 2001-04-12 2002-10-24 Medicarb Ab An effervescent solid composition of matter
SE522529C2 (sv) * 2001-04-12 2004-02-17 Medicarb Ab Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
KR100473445B1 (ko) * 2001-05-10 2005-03-08 씨제이 주식회사 저분자 키토산과 ε-폴리라이신을 주원료로 하는 콜레스테롤 저하제 및 건강 보조 식품
ES2209632B1 (es) * 2002-08-30 2005-08-01 Romildo Holding, N.V. Complemento dietetico, soluble, efervescente y alimenticio.
EA200870059A1 (ru) * 2005-12-16 2008-12-30 ДиЭнПи КЭНАДА ИНК. Производные хитина для применения при гиперлипидемии
CN101678039A (zh) * 2006-12-07 2010-03-24 本巴科技2006有限公司 采用疏水性微米微粒的用于减少胆固醇的混合物与方法
EP2016946B1 (en) * 2007-07-18 2013-02-27 The Jordanian Pharmaceutical Manufacturing Co. Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
CN102504291B (zh) * 2011-10-28 2014-01-01 北京联合大学生物化学工程学院 pH敏感型壳聚糖交联聚维酮凝胶及其制备方法和应用
CN115568321B (zh) * 2022-09-16 2024-04-02 江苏省农业科学院 一种延长苏翠1号梨叶片生理功能期的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
FI83426C (fi) * 1989-06-30 1991-07-10 Firextra Oy Foerfarande foer kontinuerlig framstaellning av mikrokristallin kitosan.
JPH07100040B2 (ja) * 1992-11-24 1995-11-01 朝日食品工業株式会社 キトサンおよび/またはその部分分解物の分子量分布測定方法
FI107432B (fi) * 1997-02-06 2001-08-15 Novasso Oy Mikrokiteisen kitosaanin käyttö

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006029524A1 (en) * 2004-09-15 2006-03-23 Magistral Biotech Inc. Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia

Also Published As

Publication number Publication date
WO2000024785A1 (en) 2000-05-04
AU1048600A (en) 2000-05-15
FI982291A0 (fi) 1998-10-23
JP2002528571A (ja) 2002-09-03
EP1144458A1 (en) 2001-10-17
CN1331703A (zh) 2002-01-16
FI982291A (fi) 2000-04-24

Similar Documents

Publication Publication Date Title
JP2667351B2 (ja) 食餌脂質消化吸収阻害剤および飲食品
Younes et al. Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats
JP6526021B2 (ja) 食事性脂肪吸収の低下における使用のためのオクラを含む組成物
CA2347967A1 (en) Substance for reduction of cholesterol as well as lipids content
JP2015516372A (ja) ペットにおける、抗酸化、腸管内菌叢、及び免疫を高めるための組成物、及び方法
TR201810187T4 (tr) Diyetsel yağ emilimini azaltma amaçlı bileşim.
AU2016253140B2 (en) Plant extracts for the treatment of excess weight and obesity
Ullrich Evaluation of a high-fiber diet in hyperlipidemia: a review.
US8426567B2 (en) Method for enhancing mammalian immunological function
US20070098763A1 (en) Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
Schaus et al. Bioavailability of vitamin E in rats fed graded levels of pectin
US4175124A (en) Method of treating hypercholesterolemia
US20070167395A1 (en) Compositions and methods for treating diabetes
MIYOSHI et al. Effects of rice fiber on fecal weight, apparent digestibility of energy, nitrogen and fat, and degradation of neutral detergent fiber in young men
US5773427A (en) Prevention of fiber-induced intestinal gas production by chitosan
Lipsky et al. Dietary fiber for reducing blood cholesterol
JP2872635B2 (ja) 健康食品
Preuss et al. Chitosan as a dietary supplement for weight loss: a review
KR20200043555A (ko) 다이어트용 보조식품 조성물
US6506420B2 (en) Combinations of psyllium and chitosan for synergistic adsorption of triglyceride
JP2004329047A (ja) 栄養補助食品
Swidan et al. Ability of two comestible formulations of hydroxypropylmethylcellulose to lower serum cholesterol concentrations
WO2023112974A1 (ja) 海藻抽出物を含む高血圧症改善剤並びに同高血圧症改善剤を含む機能性食品、医薬部外品及び医薬品
US20230241143A1 (en) Method of Improving Resilience and Recovery in Healthy Mammals
KR100450055B1 (ko) 두과 식물을 주성분으로 함유하는 체질개선용 식품 조성물및 그로부터 제조되는 식품

Legal Events

Date Code Title Description
FZDE Dead